Some Molecular and Clinical Aspects of Genetic Predisposition to Malignant Melanoma and Tumours of Various Site of Origin
<p>Abstract</p> <p>Based on epidemiological data we can assume that at least some malignant melanoma (MM) and breast cancer cases can be caused by the same genetic factors. <it>CDKN2A</it>, which encodes the p16 protein, a cyclin-dependent kinase inhibitor suppressing c...
Main Author: | Dębniak Tadeusz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://www.hccpjournal.com/content/5/2/97 |
Similar Items
-
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
by: Milena Casula, et al.
Published: (2019-08-01) -
Analiza mutacji p14 i p16 w czerniaku skóry
by: Wojciech Biernat, et al.
Published: (2011-07-01) -
CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition
by: Sock Hoai Chan, et al.
Published: (2021-03-01) -
Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History
by: Mary O’Reilly, et al.
Published: (2021-03-01) -
Dziedziczne podłoże czerniaka – wyniki badań własnych na tle piśmiennictwa
by: Tadeusz Dębniak, et al.
Published: (2011-07-01)